Legend Biotech Corporation
LEGN
$18.55
-$0.55-2.88%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 948.60M | 992.59M | 967.56M | 1.01B | 1.12B |
| Total Receivables | 250.30M | 202.57M | 228.99M | 166.85M | 125.10M |
| Inventory | 32.00M | 29.18M | 35.59M | 30.93M | 23.90M |
| Prepaid Expenses | 14.60M | 17.59M | 17.67M | 15.56M | 12.30M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.60M | 70.00K | 70.00K | 70.00K | -- |
| Total Current Assets | 1.25B | 1.24B | 1.25B | 1.22B | 1.28B |
|
|
|||||
| Total Current Assets | 1.25B | 1.24B | 1.25B | 1.22B | 1.28B |
| Net Property, Plant & Equipment | 401.50M | 253.74M | 233.60M | 206.03M | 201.20M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | 2.14M | 2.08M | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 85.10M | 217.20M | 204.31M | 188.74M | 185.10M |
| Total Assets | 1.73B | 1.71B | 1.69B | 1.62B | 1.67B |
|
|
|||||
| Total Accounts Payable | 83.00M | 102.46M | 75.36M | 58.14M | 38.60M |
| Total Accrued Expenses | 123.00M | -- | -- | 57.82M | 64.50M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 326.50M | 150.25M | 5.91M | 5.34M | 4.80M |
| Total Finance Division Other Current Liabilities | 103.90M | 180.87M | 184.22M | 113.07M | 169.80M |
| Total Other Current Liabilities | 103.90M | 180.87M | 184.22M | 113.07M | 169.80M |
| Total Current Liabilities | 636.40M | 433.57M | 265.48M | 234.37M | 277.70M |
|
|
|||||
| Total Current Liabilities | 636.40M | 433.57M | 265.48M | 234.37M | 277.70M |
| Long-Term Debt | -- | 171.93M | 310.26M | 305.75M | 301.20M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 87.20M | 88.06M | 71.74M | 51.72M | 44.60M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 8.00M | 8.13M | 6.89M | 6.06M | 6.10M |
| Total Liabilities | 731.60M | 701.69M | 654.38M | 597.90M | 629.60M |
|
|
|||||
| Common Stock & APIC | 2.75B | 2.74B | 2.73B | 2.71B | 2.70B |
| Retained Earnings | -1.96B | -1.93B | -1.89B | -1.76B | -1.66B |
| Treasury Stock & Other | 210.20M | 200.63M | 189.14M | 67.52M | 6.20M |
| Total Common Equity | 1.00B | 1.01B | 1.04B | 1.02B | 1.04B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.00B | 1.01B | 1.04B | 1.02B | 1.04B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.00B | 1.01B | 1.04B | 1.02B | 1.04B |
|
|
|||||